Y-Mabs Therapeutics's total assets for Q3 2024 were $120.92M, a decrease of -16.05% from the previous quarter. YMAB total liabilities were $28.49M for the fiscal quarter, a -41.50% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.